Notably, our correlation analysis among circulating miRNA levels and relevant clinical measures/indices of glycemic control and β-cell function, we uncovered a switch in the sign of several correlations as we compared relevant partial correlations calculated for each independent group not subjected to exogenous insulin therapy (Healthy, Prediabetes, and T2D groups). This evidence concerns the gene INS and type 2 diabetes mellitus.